Clinical Utility of Next-Generation Sequencing-Based Molecular Panel in Thyroid Nodules
NGS-based assays provide a reliable and cost-effective option for ruling out malignancy in ITNs in India, offering a high negative predictive value and complementing ACR-TIRADS and Bethesda cytology classifications.
Authors
- Basavaraj G. Sooragonda (ORCID: https://orcid.org/0009-0008-2954-8770)
- Akhila Lakshmikantha (ORCID: https://orcid.org/0000-0001-8846-9986)
- Subramanian Kannan (ORCID: https://orcid.org/0000-0003-4941-4821)
- Vidhya Bhushan
- Suruchi Aggarwal (ORCID: https://orcid.org/0000-0002-3921-321X)
- Vijay Pillai (ORCID: https://orcid.org/0000-0002-3923-9348)
- Hetashvi Gondaliya
- Yogesh Dokhe (ORCID: https://orcid.org/0000-0002-4731-8329)
- Vivek Shetty (ORCID: https://orcid.org/0000-0002-9171-7319)
- Kranti Khadilkar
- Anirudh J. Shetty
- Shivaprasad S. Kumbenahalli
Institutions
- Narayana Health (IN)
- SciGenom Labs (India) (IN)
Publication Details
- Journal
- Indian Journal of Endocrinology and Metabolism
- Published
- 2025-03-01
- DOI
- https://doi.org/10.4103/ijem.ijem_313_24
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00